Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 29, 2025: USD 396.75 M

Charles River Laboratories International, Inc. Depreciation And Amortization is USD 396.75 M for the Trailing 12 Months (TTM) ending March 29, 2025, a 23.06% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 322.41 M, a 5.49% change year over year.
  • Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 305.64 M, a 9.42% change year over year.
  • Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 26, 2022 was USD 279.33 M, a 16.79% change year over year.
  • Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 27, 2021 was USD 239.17 M, a 13.89% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased